Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Jazz

Recent news which mentions Jazz

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Got $2,000? Buy These 2 Bear Market-Beating Growth Stocks
Tickers ABBV JAZZ
Tags JAZZ Recent Press Releases ABBV
From Motley Fool
Japan Is Inching Toward Cannabis Legalization, Companies Like This One Could Benefit
Tickers JAZZ
Tags Politics Epidiolex Markets
From Benzinga
UBS Slashes PT On This Stock By Over 89%? Plus Evercore ISI Group Predicts $150 For First Solar
Tickers AAPL FSLR HUYA IMVT
Tags WY FSLR Market News
From Benzinga
If You Invested $10,000 in Axsome Therapeutics 5 Years Ago, This Is How Much You Would Have Today
Tickers AXSM JAZZ
Tags JAZZ Recent Press Releases Market News
From Motley Fool
2 Reasons to Buy Axsome Therapeutics, and 1 Reason to Sell
Tickers AXSM JAZZ
Tags AXSM Market News JAZZ
From Motley Fool
5 Analysts Have This to Say About Jazz Pharmaceuticals
Tickers JAZZ
Tags Market News BZI/AAR Benzinga
From Benzinga
Is It Too Late to Buy Axsome Therapeutics Stock?
Tickers AXSM JAZZ
Tags AXSM JAZZ Recent Press Releases
From Motley Fool
7 Top-Rated Biotech Stocks to Buy for Q4
Tickers ABBV ABT ADMA AXSM
Tags ADMA VYGR Stocks to Buy
From InvestorPlace
3 Top Pot Stocks to Watch in September
Tickers IIPR JAZZ JUSHF MJ
Tags YOLO MJ IIPR
From Motley Fool
Is Axsome Therapeutics a Buy?
Tickers AXSM JAZZ
Tags AXSM Recent Press Releases JAZZ
From Motley Fool
New Music Alert! Award-Winning Artist & Music Producer, Sonix releases, 'Love Crusade,' full-length LP, & 'No Ordinary Love The Maxi Single' 9.9.2022
Tickers JAZZ
Tags Music Events New York
From PRLog
2 Growth Stocks That Are Beating Amazon Without Breaking a Sweat
Tickers AMZN CORT JAZZ
Tags Market News Recent Press Releases JAZZ
From Motley Fool
2 Top Healthcare Stocks Defying the Bear Market
Tickers ABBV JAZZ
Tags Recent Press Releases JAZZ ABBV
From Motley Fool
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
Tickers AGLE BBIO BCRX CRIS
Tags ETNB Biotech Catalysts / EOD Summary Biotech
From Benzinga
Jazz' Epidiolex, The Only FDA-Approved CBD Drug, Enters Phase 3 Trial Evaluating Its Effects In Patients With Myoclonic-Atonic Seizures
Tickers JAZZ
Tags Cannabis Market News Markets
From Benzinga
Why Axsome Therapeutics Topped the Market Today
Tickers AXSM JAZZ
Tags AXSM Market News Recent Press Releases
From Motley Fool
Jazz Pharmaceuticals' Return On Capital Employed Insights
Tickers JAZZ
Tags Benzinga Market News JAZZ
From Benzinga
'Street Underestimates Jazz Pharma's Cash-Flow' Says This Analyst
Tickers JAZZ
Tags Benzinga Health Care JAZZ
From Benzinga
Where Jazz Pharmaceuticals Stands With Analysts
Tickers JAZZ
Tags Analyst Ratings JAZZ Market News
From Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Tickers ALNY AMRN ARQT BMRN
Tags MRTX FATE FDA
From Benzinga
2 Growth Stocks That Are Unapologetically Crushing the Bear Market
Tickers IONS JAZZ
Tags IONS Recent Press Releases JAZZ
From Motley Fool
7 Biotech Stocks to Buy for Q3
Tickers ALT AMLX ARQT AXSM
Tags ICPT MS Stocks to Buy
From InvestorPlace
Needham Previews Neurocrine's Upcoming Mid-Stage Data from Essential Tremor Study
Tickers JAZZ NBIX PRAX
Tags Analyst Color Briefs Biotech
From Benzinga
Why BioXcel Therapeutics Was a Winner This Week
Tickers BTAI JAZZ
Tags Market News Recent Press Releases JAZZ
From Motley Fool
This Exciting Growth Sector Is Predicted to Keep Doubling Until 2028
Tickers JAZZ PFE
Tags PFE JAZZ Recent Press Releases
From Motley Fool
Brazilian Fund Invests $19M In US Cannabis Stocks
Tickers ACB CARA CBD CGC
Tags Market News ACB CNTTQ
From Benzinga
What Bear Market? These 2 Stocks Are Killing It.
Tickers JAZZ LLY
Tags LLY Market News Recent Press Releases
From Motley Fool
What SVB Says On Axsome's Strategy Review On Sunosi For Sleeping Disorder
Tickers AXSM JAZZ
Tags Biotech Briefs Small Cap
From Benzinga
Jazz Pharmaceuticals' Late-Stage Multiple Sclerosis Study Misses Primary Endpoint
Tickers JAZZ
Tags General Market News Biotech
From Benzinga
Jazz Pharma's Cannabidiol Mixture Spray Misses Primary Goal In Multiple Sclerosis Spasticity
Tickers JAZZ
Tags JAZZ Benzinga Health Care
From Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.